Melatonin can induce programmed cell death, or apoptosis, in cancer cells, reducing tumor size and proliferation by inhibiting the production of growth factors related to cancer development such as epidermal growth factor (EGF) and insulin-like growth factor 1 (IGF-1)24,25. The gene discussed is IGF1; the disease is neoplasm.